Board committees

Board of Directors:

Anders Ekblom

Chairman of the Board

Chairman of the Board since 2021
Chairman of the Remuneration Committee
Born 1954

Education: M.D., Board certified in Anesthesiology and Intensive Care, D.D.S., Associate Professor in Physiology, Karolinska Institutet

Other current activities: Chairman of the Board of Elypta AB, Deputy Chairman of the Board of LEO Pharma A/S, Director of the Board of AnaMar AB, Alligator Bioscience AB and Mereo BioPharma Group plc

Previous assignments (the recent 5 years): Chairman of the Board of TFS International AB, Director of the Board of Infant Bacterial Therapy AB and Medivir AB

Holdings: 3,000 shares

Independent in relation to the Company and its management, and in relation to major shareholders

Anders Bladh

Board member since 2021

Member of the Remuneration Committee
Born 1958

Education: Bachelor of Science in Business Administration and Economics, University of Uppsala

Other current activities: Owner, member of the Board, as well as CEO of Intervalor AB, Ribbskottet AB, and Rimturs AB

Holdings: 138,695 shares, and 2,150,000 shares via company Ribbskottet AB

Gunnar Gårdemyr

Board member

Board member since 2019
Member of the Remuneration Committee
Born 1959

Education: BSc Economy, University of Lund

Other current activities: Other current assignments: Chairman of the Board in Rhovac AB, Iconovo AB, and Asgard Therapeutics

Previous assignments (the recent 5 years): CEO Targovax AS, Norge, CBO in Follicum AB

Holdings: 4,400 shares

Independent in relation to the Company and its management and in relation to major shareholders

Maris Hartmanis

Board member

Board member since 2015
Chairman of the Audit Committee
Born 1953

Education: Dr. of Technology and Associate Professor, Royal Institute of Technology

Other current activities: Other current activities: CEO and Chairman of the Board in Hartmanis & Partners AB as well as board member in BioLamina, CEO and Chairman of the foundation FINGERS Brain Health Institute

Previous assignments (the recent 5 years): Board member in Xbrane Biopharma AB, karolinska Institutet Holding AB and Applied Photophysics Ltd., England, and vice Chairman of the Board in ProNova, a VINNOVA Center of Excellence for protein technology at Kungliga Tekniska Högskolan

Holdings: 28,619 shares

Independent in relation to the Company and its management and in relation to major shareholders

Torbjörn Koivisto

Board member

Board member since 2017
Member of the Remuneration Committee
Born 1969

Education: Master of Laws (LL.M.), University of Uppsala

Other current activities: Other current activities: Board member of Hemcheck Sweden AB, Cinclus Pharma Holding AB and IARU Institutet för Affärsjuridisk Rådgivning I Uppsala AB, partner in KOL Arts & Craft Handelsbolag as well as deputy of RJC Roger Johansson Consulting AB

Holdings: 4,000 shares via company (IARU)

Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind

Board member

Board member since 2019
Member of the Audit Committee
Born 1974

Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School

Other current activities: Other current activities: VP Commercial of NDA Group AB, chairman and CEO of Lind Growth Strategy AB, chairman of the board in Immunicum AB and deputy board member of Shinka Life Sciences AB

Previous assignments (the recent 5 years): CEO as well as EVP Business Development of Medivir AB

Holdings: 4,000 shares

Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak

Board member

Board member since 2015
Member of the Audit Committee
Born 1956

Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet

Other current activities: Other current assignment: Board member of Atrogi AB, Empros Pharma AB, Follicum AB, KAHR Medical Ltd., Pharmacolog in Uppsala AB (publ), Prokarium Ltd., SwedenBIO Service AB, and Symcel AB, and deputy in Buzzard Pharmaceuticals AB

Previous assignments (the recent 5 years): Chairman of the board in Bostadsrättsföreningen Smultronhyllan, Cobra Biologics Matfors AB, Cobra Biopharma Matfors AB, Cobra Biologics Holding AB, Recipharm OT Chemistry AB and Recipharm Pharmaceutical Development AB, member of board as well as CEO of Recipharm Venture Fund AB. Member of the board in Binx Helth Ltd, UK, Inject Pharma Sweden AB, Synthonics, Inc., Pharmanest AB, Recipharm OT Chemistry AB och Recipharm Strängnäs AB and deputy member of the board in Cobra Biologics AB och Cormorant Pharmaceuticals AB

Holdings: None

Independent in relation to the Company and its management and in relation to major shareholders

Committees:

Audit Committee

  • Maris Hartmanis, Chairman
  • Christine Lind
  • Carl-Johan Spak

Remuneration Committee

  • Anders Ekblom, Chairman
  • Anders Bladh
  • Torbjörn Koivisto